Beta‐blockers vs placebo
The review found no eligible studies for this question.
- Pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether calcium channel blockers changes improvement in vertigo severity compared with no intervention (very low certainty).
It is very uncertain whether betahistine changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
It is very uncertain whether diuretic changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
It is very uncertain whether calcium channel blockers changes improvement in vertigo frequency compared with no intervention (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether triptans changes improvement in vertigo (global score) ‐ up to 2 hours compared with placebo (very low certainty).